Hanwha Solutions, one of South Korea's largest chemicals and renewable energy conglomerates, revised its rights offering from 2.4 trillion KRW down to 1.8144 trillion KRW (approx. USD 1.3 billion) following pressure from South Korea's financial regulator FSS.
Key Facts:
- New shares: 56 million shares at KRW 32,400 (~20% discount to April market price)
- Dilution rate: ~20.7% of total shares outstanding
- Shareholder record date: May 14, 2026
- Subscription window (existing shareholders): June 22-23, 2026
- Final price confirmation: June 17, 2026
Why it was cut: The FSS flagged that over 62% of proceeds were earmarked for debt repayment, leaving insufficient growth investment rationale. After the regulator's demand, Hanwha restructured the allocation to a 50/50 split between debt reduction (KRW 906.7B) and capex (KRW 907.7B).
Financial context: Hanwha Solutions posted an operating loss of KRW 353.3 billion in 2025 (second consecutive year in the red) with a debt-to-equity ratio of 196.3%, significantly above peers LG Chem (114.5%) and Lotte Chemical (76.5%).
Investor takeaway: The subscription price of KRW 32,400 appears attractive vs the April market price of ~KRW 40,500, but 20.7% dilution is substantial. The key variable is whether Q1 2026 results (due May) confirm a return to profitability in solar modules. If operating income recovery is visible, participation logic strengthens.
For the full analysis in Korean, visit Snakestock.
